David E. Alonzo
Impact in
- Pharmaceutical Science top 0.1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Analytical Chemistry top 1%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Drug Solubulity and Delivery Systems 12
-
- Crystallization and Solubility Studies 12
- Co-authors
- Lynne S. Taylor (12 shared papers)Yi Gao (8 shared papers)Geoff G. Z. Zhang (8 shared papers)Deliang Zhou (3 shared papers)Shweta A. Raina (6 shared papers)Tetsurou Handa (1 shared paper)Huaping Mo (2 shared papers)Donghua Zhu (2 shared papers)
- Journals
- Pharmaceutical Research (5 papers)Journal of Pharmaceutical Sciences (3 papers)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Molecular Pharmaceutics (1 paper)Crystal Growth & Design (1 paper)
- Partner nations
- United StatesBelgiumJapan
In The Last Decade
David E. Alonzo
13 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 1.5k
- Analytical Chemistry 280
- Materials Chemistry 1.0k
- Spectroscopy 366
- Pharmacology 106
Countries citing papers authored by David E. Alonzo
This map shows the geographic impact of David E. Alonzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Alonzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Alonzo more than expected).
Fields of papers citing papers by David E. Alonzo
This network shows the impact of papers produced by David E. Alonzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Alonzo. The network helps show where David E. Alonzo may publish in the future.
Co-authors
The 15 scholars most cited alongside David E. Alonzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 393 | |
| 2 | 2008 | 327 | |
| 3 | 2011 | 232 | |
| 4 | 2009 | 164 | |
| 5 | 2013 | 161 | |
| 6 | 2012 | 125 | |
| 7 | 2015 | 114 | |
| 8 | 2015 | 82 | |
| 9 | 2011 | 68 | |
| 10 | 2014 | 51 | |
| 11 | 2015 | 45 | |
| 12 | 2012 | 34 | |
| 13 | Maximizing the solubility advantage of amorphous pharmaceutical systems | 2010 | 1 |
About David E. Alonzo
David E. Alonzo is a scholar working on Pharmaceutical Science, Materials Chemistry, Analytical Chemistry, Organic Chemistry and Spectroscopy, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (12 papers), Crystallization and Solubility Studies (12 papers), Analytical Methods in Pharmaceuticals (5 papers), Surfactants and Colloidal Systems (2 papers), Analytical Chemistry and Chromatography (2 papers), Microencapsulation and Drying Processes (2 papers), Drug Transport and Resistance Mechanisms (1 paper) and Protein purification and stability (1 paper). The work is most often cited by research in Pharmaceutical Science (1.5k citations), Analytical Chemistry (280 citations), Materials Chemistry (1.0k citations), Spectroscopy (366 citations) and Pharmacology (106 citations). David E. Alonzo has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Lynne S. Taylor, Yi Gao, Geoff G. Z. Zhang, Deliang Zhou, Shweta A. Raina, Tetsurou Handa, Huaping Mo, Donghua Zhu, Bernard Van Eerdenbrugh and Jian Wu. Their work appears in journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics, Molecular Pharmaceutics and Crystal Growth & Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.